Volume 19, Number 5—May 2013
Research
World Health Organization International Standard to Harmonize Assays for Detection of Hepatitis E Virus RNA
Table 2
Assay type and sample | No. | Mean (95% CI)† | SD | % CV |
---|---|---|---|---|
Quantitative | ||||
1 | 123 | 5.58 (5.32–5.85) | 0.54 | 98 |
2 | 125 | 5.60 (5.33–5.87) | 0.53 | 94 |
1 + 2 | 248 | 5.59 (5.33–5.86) | 0.55 | 99 |
3 | 124 | 5.66 (5.40–5.93) | 0.45 | 77 |
4 | 125 | 5.66 (5.40–5.93) | 0.44 | 76 |
3 + 4 |
249 |
5.66 (5.40–5.93) |
0.44 |
76 |
Qualitative | ||||
1 | 19 | 5.25 (5.01–5.50) | 0.51 | 150 |
2 | 20 | 5.26 (4.97–5.56) | 0.62 | 179 |
1 + 2 | 39 | 5.26 (5.08–5.44) | 0.56 | 163 |
3 | 20 | 5.27 (4.90–5.64) | 0.79 | 226 |
4 | 20 | 5.31 (5.02–5.61) | 0.64 | 183 |
3 + 4 | 40 | 5.29 (5.07–5.52) | 0.71 | 202 |
*Samples 1 and 2, replicate samples of the candidate WHO International Standard; samples 3 and 4, replicate samples of the candidate Japanese national standard. HEV, hepatitis E virus; WHO, World Health Organization; NAT, nucleic acid amplification technique; no., no. dilutions analyzed (in linear range for quantitative assays); % CV, geometric coefficient of variation.
†Values are log10 copies/mL for quantitative and log10 NAT–detectable units/mL for qualitative assays.
1Members of the HEV Collaborative Study Group are listed at the end of this article.
2In memory of Thomas Laue.
Page created: April 01, 2013
Page updated: April 01, 2013
Page reviewed: April 01, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.